Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 AlteredExpression disease BEFREE Besides PYCR1, we found that additional proline biosynthetic enzymes, such as ALDH18A1, were upregulated in HCC models and also regulated HCC cell proliferation. 31726117 2020
CUI: C0268540
Disease: HHH syndrome
HHH syndrome
0.010 Biomarker disease BEFREE Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism. 30853934 2019
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.010 Biomarker phenotype BEFREE SPG9B might involve a complicated HSP including cerebellar ataxia and cognitive impairment. 29915212 2018
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.010 Biomarker disease BEFREE SPG9B might involve a complicated HSP including cerebellar ataxia and cognitive impairment. 29915212 2018
Complicated hereditary spastic paraplegia
0.010 GeneticVariation disease BEFREE Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment. 29915212 2018
Spastic paraplegia type 5A, recessive
0.010 GeneticVariation disease BEFREE We present a 19-year old male patient with autosomal recessive spastic paraplegia and compound heterozygosity for two ALDH18A1 mutations, one in each of the P5CS domains. 29754261 2018
CUI: C3642345
Disease: Luminal A Breast Carcinoma
Luminal A Breast Carcinoma
0.010 AlteredExpression disease BEFREE High ALDH18A1 and high GLS protein expression was observed in the oestrogen receptor (ER)+/human epidermal growth factor receptor (HER2)- high proliferation class (Luminal B) compared with ER+/HER2- low proliferation class (Luminal A) (P=0.030 and P=0.022 respectively), however this was not observed with mRNA. 29169183 2018
CUI: C3642346
Disease: Luminal B Breast Carcinoma
Luminal B Breast Carcinoma
0.010 AlteredExpression disease BEFREE High ALDH18A1 and high GLS protein expression was observed in the oestrogen receptor (ER)+/human epidermal growth factor receptor (HER2)- high proliferation class (Luminal B) compared with ER+/HER2- low proliferation class (Luminal A) (P=0.030 and P=0.022 respectively), however this was not observed with mRNA. 29169183 2018
CUI: C4021790
Disease: Abnormality of the skeletal system
Abnormality of the skeletal system
0.010 GeneticVariation disease BEFREE Autosomal dominant (AD) complex HSP with skeletal abnormalities are consistently seen only in SPG9 (spastic gait type 9). 30029526 2018
CUI: C4529962
Disease: Fatty Liver Disease
Fatty Liver Disease
0.010 Biomarker disease BEFREE Some of the novel aberrant gene expression, mutations and core oncogenic pathways identified in cholesterol-associated NASH-HCCs in mice were confirmed in human NASH-HCCs, which included metabolism-related genes (ALDH18A1, CAD, CHKA, POLD4, PSPH and SQLE) and recurrently mutated genes (RYR1, MTOR, SDK1, CACNA1H and RYR2). 30367044 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 Biomarker phenotype BEFREE GSAS/N5 cells that had been injected into the nude mouse tongue and harvested from metastasized lungs multiplied angiopoietin-like 4 (angptl4) expression with enhanced migration activity, which indicated a possible involvement of angptl4 in lung metastasis of the cells. 27511626 2016
Secondary malignant neoplasm of lung
0.010 AlteredExpression disease BEFREE GSAS/N5 cells that had been injected into the nude mouse tongue and harvested from metastasized lungs multiplied angiopoietin-like 4 (angptl4) expression with enhanced migration activity, which indicated a possible involvement of angptl4 in lung metastasis of the cells. 27511626 2016
CUI: C0025202
Disease: melanoma
melanoma
0.010 Biomarker disease BEFREE Thus, targeting ALDH18A1 in melanoma can be used to disrupt proline biosynthesis to limit cell metabolism thereby increasing the cellular doubling time mediated through the GCN2 pathway. 26082174 2015
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE Inhibition of ALDH18A1, the gene encoding pyrroline-5-carboxylate synthase (P5CS), significantly decreased cultured melanoma cell viability and tumor growth. 26082174 2015
CUI: C0033300
Disease: Progeria
Progeria
0.010 GeneticVariation disease BEFREE In conclusion, the clinical phenotype caused by ALDH18A1 mutations is diverse, with variable degree of progeria in children, but always in association with neurologic disease. 24767728 2014
CUI: C0035309
Disease: Retinal Diseases
Retinal Diseases
0.010 GeneticVariation group BEFREE Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature. 24767728 2014
CUI: C0035334
Disease: Retinitis Pigmentosa
Retinitis Pigmentosa
0.010 Biomarker disease BEFREE Furthermore, abnormal fat distribution, retinal abnormalities, undescended testis, and retinitis pigmentosa have never been described in ALDH18A1. 24767728 2014
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 GeneticVariation disease BEFREE Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations. 23963297 2014
CUI: C0431369
Disease: Dysgenesis of corpus callosum
Dysgenesis of corpus callosum
0.010 GeneticVariation disease BEFREE Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations. 23963297 2014
CUI: C1112321
Disease: Congenital cutis laxa
Congenital cutis laxa
0.010 GeneticVariation disease BEFREE Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1. 24913064 2014
CUI: C3665335
Disease: Cutis laxa, autosomal recessive
Cutis laxa, autosomal recessive
0.010 Biomarker disease BEFREE ALDH18A1-related ARCL is the most severe form within this disease spectrum. 24913064 2014
Dementia due to Alzheimer's disease (disorder)
0.010 Biomarker disease BEFREE Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome. 20946940 2011
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.010 AlteredExpression group BEFREE The deficiency of P5CS activity in humans is associated with a rare, inherited metabolic disease. 20091669 2010
CUI: C0016202
Disease: Flatfoot
Flatfoot
0.010 Biomarker phenotype BEFREE Recently, we reported a newly recognised inborn error due to deficiency of P5CS in two sibs, one presenting at birth with hypotonia, dysmorphic signs, pes planus and clonic seizures. 15517380 2005
CUI: C0234535
Disease: Clonic Seizures
Clonic Seizures
0.010 Biomarker disease BEFREE Recently, we reported a newly recognised inborn error due to deficiency of P5CS in two sibs, one presenting at birth with hypotonia, dysmorphic signs, pes planus and clonic seizures. 15517380 2005